Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma

Cutaneous Melanoma (CM) is an aggressive cancer whose incidence is increasing worldwide. However, the knowledge of its biology and genes driving cell growth and survival allowed to develop new drugs that have improved PFS and OS of advanced disease. Both BRAF targeting agents and immune checkpoint i...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconcini, Riccardo, Pezzicoli, Gaetano, Stucci, Luigia Stefania, Sergi, Maria Chiara, Lospalluti, Lucia, Porta, Camillo, Tucci, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Melanoma Immunotherapy SF – Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302493/
https://www.ncbi.nlm.nih.gov/pubmed/34613889
http://dx.doi.org/10.1080/21645515.2021.1980315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302493/
https://www.ncbi.nlm.nih.gov/pubmed/34613889
http://dx.doi.org/10.1080/21645515.2021.1980315

Ejemplares similares